Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 212

Trial Status

Completed5
Recruiting4
Terminated1
Other3

Role Distribution

Principal Investigator12
Other Roles1
PI Rate92%

Activity Timeline

Clinical Trials (13)

NCT07013565Phase 2Recruiting
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Anaplastic Large Cell Lymphoma, ALK-Positive
PrincipalinvestigatorStart date: 2025-08-07
NCT04896606Phase 1/2Recruiting
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
Covid19
StudychairStart date: 2021-09-20
NCT04197596Phase 1/2Recruiting
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Primary Immune Deficiency DisorderViral Infection
PrincipalinvestigatorStart date: 2020-07-01
NCT03266640Phase 2Recruiting
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
PrincipalinvestigatorStart date: 2018-11-01
NCT03805581Phase 2Completed
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
Acute Chest SyndromeSickle Cell Disease
PrincipalinvestigatorStart date: 2018-01-12
NCT01586455Phase 1Completed
Human Placental-Derived Stem Cell Transplantation
Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaAdrenoleukodystrophy+13 more
PrincipalinvestigatorStart date: 2013-04-01
NCT01859819Phase 2Completed
Treatment for Advanced B-Cell Lymphoma
Burkitt's LymphomaDiffuse Large Cell LymphomaHigh Grade B-cell Lymphoma
PrincipalinvestigatorStart date: 2013-01-01
NCT02221310Phase 2Completed
Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
PrincipalinvestigatorStart date: 2011-12-07
NCT01049854Phase 2Completed
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Beta ThalassemiaBone Marrow FailureHistiocytosis+5 more
Principalinvestigator
NCT01461837Phase 2Active Not Recruiting
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Sickle Cell Disease
Principalinvestigator

Showing 10 of 13 trials

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanton Goldman, MD

Medical City Children's Hospital, Dallas

Moderately Similar
1 trials

Shared therapeutic areas:

Burkitt LymphomaLymphoma, Large B-Cell, DiffuseHigh Grade B-Cell Lymphoma

Worked with same sponsors:

New York Medical College
Collaborated on 1 trial
Similarity Score34%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaLeukemia, Myeloid, Acute+5 more

Worked with same sponsors:

Medical College of Wisconsin
Similarity Score7%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaClassical Hodgkin LymphomaHodgkin Disease+5 more

Worked with same sponsors:

Baylor College of MedicineChildren's Hospital Los Angeles+2 more
Similarity Score7%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteMyelodysplastic Syndromes+2 more

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score4%

Peter Bauer, Prof.

Centogene GmbH

Related
25 trials

Shared therapeutic areas:

Metabolism, Inborn ErrorsWolman DiseaseLeukodystrophy, Globoid Cell+2 more
Similarity Score4%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score3%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more

Worked with same sponsors:

CelgeneM.D. Anderson Cancer Center
Similarity Score3%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphomaMyelodysplastic Syndromes
Similarity Score3%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaHodgkin Disease

Worked with same sponsors:

Johns Hopkins UniversityM.D. Anderson Cancer Center+1 more
Similarity Score3%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT07013565Phase 2PrincipalInvestigator

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

Anaplastic Large Cell Lymphoma, ALK-Positive
Recruiting
NCT04896606Phase 1/2StudyChair

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Covid19
Recruiting
NCT04197596Phase 1/2PrincipalInvestigator

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Primary Immune Deficiency DisorderViral Infection
Recruiting
NCT03266640Phase 2PrincipalInvestigator

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
Recruiting
NCT03805581Phase 2PrincipalInvestigator

Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

Acute Chest SyndromeSickle Cell Disease
Completed
NCT01586455Phase 1PrincipalInvestigator

Human Placental-Derived Stem Cell Transplantation

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaAdrenoleukodystrophy+13 more
Completed
NCT01859819Phase 2PrincipalInvestigator

Treatment for Advanced B-Cell Lymphoma

Burkitt's LymphomaDiffuse Large Cell LymphomaHigh Grade B-cell Lymphoma
Completed
NCT02221310Phase 2PrincipalInvestigator

Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS

Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Completed
NCT01049854Phase 2PrincipalInvestigator

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Beta ThalassemiaBone Marrow FailureHistiocytosis+5 more
Completed
NCT01461837Phase 2PrincipalInvestigator

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Sickle Cell Disease
Active Not Recruiting
NCT01636388Phase 2PrincipalInvestigator

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Hodgkins Lymphoma
Terminated
NCT02434965Phase 2PrincipalInvestigator

Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy

Severe Hypoxic-ischemic Encephalopathy
Withdrawn
NCT06617286Phase 1/2PrincipalInvestigator

CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma

Classical Hodgkin Lymphoma
Not Yet Recruiting

All 13 trials loaded